Boothbay Fund Management’s Spyre Therapeutics SYRE Stock Holding History

Boothbay Fund Management’s Portfolio SYRE Stock Details SYRE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.74M	Buy
2025 Q1	–	Sell
2024 Q4	$1.99M	Sell
2024 Q3	$2.7M	Buy
2020 Q4	–	Sell
2020 Q3	$75K	Buy